What are Psychedelic Drugs?

Psychedelic drugs, also known as hallucinogens, are a category of psychoactive substances that produce changes in perception, mood, and thought. These substances can cause users to experience visual or auditory hallucinations and a distorted sense of time and reality. Common examples include LSD (lysergic acid diethylamide), psilocybin (magic mushrooms), and mescaline (from peyote cactus).

In the context of mental health and addiction treatment, psychedelic drugs are being explored for their potential therapeutic benefits, especially in the treatment of depression, PTSD, and substance use disorders. However, their use outside controlled clinical settings can be risky, as they may trigger psychosis or exacerbate underlying mental health conditions.

Legally, many psychedelic drugs are classified as Schedule I substances under federal law in the United States, meaning they are considered to have a high potential for abuse and no accepted medical use. Nonetheless, recent studies and decriminalization movements are challenging these classifications and advocating for controlled therapeutic use.

It’s important for addiction treatment programs to assess a client’s use of psychedelics within a broader context of psychological history and drug use patterns. While not traditionally considered physically addictive, these substances can lead to psychological dependence and risky behaviors if misused.